Can Inhaling Microplastics Affect the Lungs?

Studies have measured inhalable microplastics in indoor air and reported plastic particles in human sputum, bronchoalveolar lavage fluid and lung tissue. Controlled animal inhalation and high-exposure workplace studies support concern about respiratory effects. Everyday environmental inhalation, however, has not been shown to cause asthma, COPD, fibrosis, cancer or another lung disease in people.

Quick answer

Yes, people can breathe airborne microplastics. Air and respiratory-sample studies make inhalation and deposition plausible, but reported concentrations depend heavily on the room, activity, sampling method and smallest particle the instrument can detect.

Human disease evidence remains limited and largely observational. Intense occupational exposure to synthetic flock can cause a specific lung disease, but that does not establish risk from ordinary indoor air. Animal experiments support biological plausibility, although many place particles directly into the airway rather than use a naturally breathed aerosol.

For the wider evidence picture, start with PFK's microplastics and human health guide.

Three things to know

• Microplastics are present in indoor air: Counts vary widely because studies examine different rooms and particle-size ranges.
• Detection is not disease proof: Nasal lavage, sputum, lung tissue and deep-lung lavage answer different deposition questions and come from selected groups.
• Exposure route matters: Industrial flock, true aerosol inhalation and a bolus placed into an animal's trachea are not interchangeable exposures.

How the main claims hold up

Claim 1: Are microplastics present in indoor air, and can people inhale them?

PFK verdict: Yes, but there is no single universal indoor-air concentration or daily inhaled dose.

A 2019 breathing-manikin study in three apartments reported 1.7 to 16.2 particles per cubic metre above an 11-micrometre lower limit. A 2024 Raman study measuring particles above 1 micrometre in four indoor settings reported 58 to 684 per cubic metre. A method that reaches smaller sizes can count a much larger particle population.

A 2023 Shanghai study collected paired inhaled indoor aerosol and exhaled breath from 30 volunteers. Means were 43 particles per cubic metre in inhaled air and 12 in exhaled breath. This supports personal inhalation and shows why room-air models may overstate retention. The study was short-term, from one city and had no health endpoint.

Claim 2: Have microplastics been found in the human respiratory tract and lungs?

PFK verdict: Several small studies report them, but each sample represents a different site and selected population.

A 2022 surgical study identified 39 particles in 11 of 13 lung-tissue samples and reported separate blank-adjusted concentrations, with extensive contamination controls. Researchers have also reported particles in sputum from 22 respiratory patients and bronchoalveolar lavage fluid from 18 never-smokers undergoing bronchoscopy.

Sputum can include upper-airway, lower-airway and oral material. Bronchoalveolar lavage samples deeper airways but comes from people needing an invasive procedure. Lung tissue from surgery or autopsy is also clinically selected. None is a representative population survey or clinical diagnostic test.

Claim 3: Are microplastics associated with respiratory disease?

PFK verdict: Preliminary associations exist, but timing, confounding and reverse causation remain unresolved.

A chronic rhinosinusitis study compared 50 patients with 30 healthy volunteers and reported higher nasal-lavage counts in the patient group. It cannot show whether particles contributed to disease, whether inflamed airways retained or cleared them differently, or whether other exposures influenced both.

Published critical correspondence and an author response followed the paper. It remains active and unretracted, but the exchange belongs with any interpretation. In a separate preliminary study, microplastics were detected in deep-lung lavage from 10 of 18 patients suspected of interstitial lung disease. Positive control-group samples came from people later found to have chronic lung disease, limiting the comparison. Current studies do not establish microplastics as a cause of asthma, COPD, pulmonary fibrosis or lung cancer.

Claim 4: Does flock worker's lung show that ordinary indoor air is dangerous?

PFK verdict: No. It shows that intense industrial exposure to respirable synthetic fibers can cause serious occupational disease.

A 1998 investigation of all 165 workers employed at one nylon-flocking plant identified eight cases of a specific interstitial lung disease and reported at least a 48-fold sex-adjusted increase in incidence. An erratum and published comments or replies are indexed; the core article remains active. A separate study of 50 polypropylene-flock workers and 45 controls reported more symptoms, lower lung-function measures and inflammatory differences.

These are strong occupational warnings. Concentrated industrial aerosols, fiber forms and workplace conditions should not be used as a risk estimate for homes, cars or offices.

Claim 5: What do animal studies show about inhalation?

PFK verdict: They support respiratory-hazard plausibility, but the delivery route determines what the experiment can represent.

A 2021 rat study used true whole-body aerosol inhalation for 14 days. Lung TGF-beta and TNF-alpha increased with concentration, although several other changes lacked a concentration-response pattern. This models breathing more directly than a bolus, but grooming can add oral intake, and the short polystyrene experiment does not reproduce long-term mixed household exposure.

A 2024 mouse study described particles as inhaled in its title but used intratracheal instillation. Researchers placed 5-micrometre polystyrene directly into the trachea at 0.6, 3 or 15 milligrams per kilogram for 60 days. Reported collagen, barrier and inflammatory changes add mechanistic evidence, not an aerosol concentration that people naturally breathed.

Practical implications

There is no validated home air count that predicts lung disease and no clinical microplastic test for asthma, COPD or fibrosis. Do not use a particle study to change prescribed respiratory care or workplace protection. Symptoms and occupational concerns belong with qualified health and safety professionals.

Good ventilation and ordinary dust control support indoor-air quality, but current evidence does not show how much either changes retained microplastic dose or disease risk. The studies also do not justify a universal medical claim for a mask, purifier or filter. Household actions should stay proportionate while researchers identify relevant sources, particle sizes and effective controls.

PFK assessment: The inhalation pathway is real enough to study carefully. The evidence does not justify treating a typical room like a nylon-flocking plant or turning respiratory detection into proof of disease.

How PFK evaluated these claims

PFK separated room-air measurement, personal inhalation, respiratory detection, human association, occupational disease and controlled animal hazard. We checked analytical lower size limits, contamination controls, sample site, participant selection, plausible reverse causation and whether animals breathed an aerosol or received an airway bolus. Counts from unlike methods and settings were not treated as comparable.

Research reviewed August 1, 2026. This article is for educational purposes and is not medical advice. Speak with a qualified health professional about breathing symptoms and with an occupational-health professional about workplace exposure.

Sources

1. Vianello A, et al. “Simulating human exposure to indoor airborne microplastics using a Breathing Thermal Manikin.” Scientific Reports. 2019. DOI: 10.1038/s41598-019-45054-w.
2. Maurizi L, et al. “Every breath you take: High concentration of breathable microplastics in indoor environments.” Chemosphere. 2024. DOI: 10.1016/j.chemosphere.2024.142553.
3. Geng Y, et al. “Individual Exposure to Microplastics through the Inhalation Route: Comparison of Microplastics in Inhaled Indoor Aerosol and Exhaled Breath Air.” Environmental Science & Technology Letters. 2023. DOI: 10.1021/acs.estlett.3c00147.
4. Jenner LC, et al. “Detection of microplastics in human lung tissue using μFTIR spectroscopy.” Science of the Total Environment. 2022. DOI: 10.1016/j.scitotenv.2022.154907.
5. Amato-Lourenço LF, et al. “Presence of airborne microplastics in human lung tissue.” Journal of Hazardous Materials. 2021. DOI: 10.1016/j.jhazmat.2021.126124.
6. Huang S, et al. “Detection and Analysis of Microplastics in Human Sputum.” Environmental Science & Technology. 2022. DOI: 10.1021/acs.est.1c03859.
7. Qiu L, et al. “Evidence of Microplastics in Bronchoalveolar Lavage Fluid among Never-Smokers: A Prospective Case Series.” Environmental Science & Technology. 2023. DOI: 10.1021/acs.est.2c06880.
8. Taş BM, et al. “Role of Microplastics in Chronic Rhinosinusitis Without Nasal Polyps.” Laryngoscope. 2024. DOI: 10.1002/lary.30926. See the published critical correspondence and author response.
9. Alpaydin AÖ, et al. “Microplastics, as a risk factor in the development of interstitial lung disease-a preliminary study.” Environmental Pollution. 2024. DOI: 10.1016/j.envpol.2024.125054.
10. Kern DG, et al. “Flock Worker's Lung: Chronic Interstitial Lung Disease in the Nylon Flocking Industry.” Annals of Internal Medicine. 1998. DOI: 10.7326/0003-4819-129-4-199808150-00001.
11. Atis S, et al. “The respiratory effects of occupational polypropylene flock exposure.” European Respiratory Journal. 2005. DOI: 10.1183/09031936.04.00138403.
12. Lim D, et al. “Inhalation toxicity of polystyrene micro(nano)plastics using modified OECD TG 412.” Chemosphere. 2021. DOI: 10.1016/j.chemosphere.2020.128330.
13. Kang H, et al. “Inhaled polystyrene microplastics impaired lung function through pulmonary flora/TLR4-mediated iron homeostasis imbalance.” Science of the Total Environment. 2024. DOI: 10.1016/j.scitotenv.2024.174300.
14. Tran HAA, et al. “Health impacts of micro- and nanoplastics in humans: systematic review of in vivo evidence.” Environmental Health. 2026. DOI: 10.1186/s12940-026-01282-y.
15. Dmitrowicz A, et al. “Micro- and nanoplastics in human biological materials: a systematic review of detection methods and methodological challenges.” Archives of Toxicology. 2026. DOI: 10.1007/s00204-026-04392-1.